Not exact matches
If you start supplementing with more and more
formula, you will
run the
risk of having your breast milk supply diminish.
Liquidity follows quality in the long
run, but in the short
run, the willingness of investors to take additional credit
risk supports the prices calculated by the
formulas.
If you try to do that, you
run a serious
risk of abandoning the
formula when
risk is at a peak.
These inspections when performed by SOPs and SWIs are guaranteeing there is no
risk of cross-contamination, which allows the company to maximize their profitability by having the ability to
run multiple
formulas on a single line without deviation from FDA regulations.